Gregory J Brunn1, Marlo K Bungum, Geoffrey B Johnson
1Transplantation Biology and Department of Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota 55905, USA.
Toll-like receptor 4 (TLR4) signaling is inhibited by the extracellular matrix in tissues. Matrix degradation releases inhibitors, enabling TLR4 to initiate immune responses, challenging the direct stimulation model.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: